366 results on '"Marino, N."'
Search Results
2. Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
- Author
-
Pellosi DS, Moret F, Fraix A, Marino N, Maiolino S, Gaio E, Hioka N, Reddi E, Sortino S, and Quaglia F
- Subjects
Pluronic Micelles ,Sorafenib ,Chemotherapy ,Photodynamic Therapy ,Verteporfin ,Medicine (General) ,R5-920 - Abstract
Diogo Silva Pellosi,1,2,* Francesca Moret,3,* Aurore Fraix,4 Nino Marino,4 Sara Maiolino,2 Elisa Gaio,3 Noboru Hioka,1 Elena Reddi,3 Salvatore Sortino,4 Fabiana Quaglia2 1Research Nucleus of Photodynamic Therapy, Chemistry Department, State University of Maringá, Maringá, Brazil; 2Drug Delivery Laboratory, Department of Pharmacy, University of Naples Federico II, Naples, 3Cell Biology Unit, Department of Biology, University of Padova, Padua, 4Laboratory of Photochemistry, Department of Drug Sciences, University of Catania, Catania, Italy *These authors contributed equally to this work Abstract: Here, we developed Pluronic® P123/F127 (poloxamer) mixed micelles for the intravenous delivery of the anticancer drug sorafenib (SRB) or its combination with verteporfin (VP), a photosensitizer for photodynamic therapy that should complement well the cytotoxicity profile of the chemotherapeutic. SRB loading inside the core of micelles was governed by the drug:poloxamer weight ratio, while in the case of the SRB–VP combination, a mutual interference between the two drugs occurred and only specific ratios could ensure maximum loading efficiency. Coentrapment of SRB did not alter the photophysical properties of VP, confirming that SRB did not participate in any bimolecular process with the photosensitizer. Fluorescence resonance energy-transfer measurement of micelles in serum protein-containing cell-culture medium demonstrated the excellent stability of the system in physiologically relevant conditions. These results were in line with the results of the release study showing a release rate of both drugs in the presence of proteins slower than in phosphate buffer. SRB release was sustained, while VP remained substantially entrapped in the micelle core. Cytotoxicity studies in MDA-MB231 cells revealed that at 24 hours, SRB-loaded micelles were more active than free SRB only at very low SRB concentrations, while at 24+24 hours a prolonged cytotoxic effect of SRB-loaded micelles was observed, very likely mediated by the block in the S phase of the cell cycle. The combination of SRB with VP under light exposure was less cytotoxic than both the free combination and VP-loaded micelles + SRB-loaded micelles combination. This behavior was clearly explainable in terms of micelle uptake and intracellular localization. Besides the clear advantage of delivering SRB in poloxamer micelles, our results provide a clear example that each photochemotherapeutic combination needs detailed investigations on their particular interaction, and no generalization on enhanced cytotoxic effects should be derived a priori. Keywords: Pluronic® micelles, sorafenib, chemotherapy, photodynamic therapy, verteporfin
- Published
- 2016
3. Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach
- Author
-
Harms, RL, Ferrari, A, Meier, IB, Martinkova, J, Santus, E, Marino, N, Cirillo, D, Mellino, S, Solarz, SC, Tarnanas, I, Szoeke, C, Hort, J, Valencia, A, Ferretti, MT, Seixas, A, Chadha, AS, Harms, RL, Ferrari, A, Meier, IB, Martinkova, J, Santus, E, Marino, N, Cirillo, D, Mellino, S, Solarz, SC, Tarnanas, I, Szoeke, C, Hort, J, Valencia, A, Ferretti, MT, Seixas, A, and Chadha, AS
- Abstract
UNLABELLED: Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices. Their use has revolutionized clinical research by enabling high-frequency, longitudinal, and sensitive measurements. In the field of neurodegenerative diseases, an example of a digital biomarker-based technology is instrumental activities of daily living (iADL) digital medical application, a predictive biomarker of conversion from mild cognitive impairment (MCI) due to Alzheimer's disease (AD) to dementia due to AD in individuals aged 55 + . Digital biomarkers show promise to transform clinical practice. Nevertheless, their use may be affected by variables such as demographics, genetics, and phenotype. Among these factors, sex is particularly important in Alzheimer's, where men and women present with different symptoms and progression patterns that impact diagnosis. In this study, we explore sex differences in Altoida's digital medical application in a sample of 568 subjects consisting of a clinical dataset (MCI and dementia due to AD) and a healthy population. We found that a biological sex-classifier, built on digital biomarker features captured using Altoida's application, achieved a 75% ROC-AUC (receiver operating characteristic - area under curve) performance in predicting biological sex in healthy individuals, indicating significant differences in neurocognitive performance signatures between males and females. The performance dropped when we applied this classifier to more advanced stages on the AD continuum, including MCI and dementia, suggesting that sex differences might be disease-stage dependent. Our results indicate that neurocognitive performance signatures built on data from digital biomarker features are different between men and women. These results stress the need to integrate traditional approaches to dementia research with digital biomarker technologies and personalized medicine persp
- Published
- 2022
4. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
- Author
-
Portale, F, Cricrì, G, Bresolin, S, Lupi, M, Gaspari, S, Silvestri, D, Russo, B, Marino, N, Ubezio, P, Pagni, F, Vergani, P, Te Kronnie, G, Valsecchi, M, Locatelli, F, Rizzari, C, Biondi, A, Dander, E, D'Amico, G, Portale F, Cricrì G, Bresolin S, Lupi M, Gaspari S, Silvestri D, Russo B, Marino N, Ubezio P, Pagni F, Vergani P, Te Kronnie G, Valsecchi MG, Locatelli F, Rizzari C, Biondi A, Dander E, D'Amico G., Portale, F, Cricrì, G, Bresolin, S, Lupi, M, Gaspari, S, Silvestri, D, Russo, B, Marino, N, Ubezio, P, Pagni, F, Vergani, P, Te Kronnie, G, Valsecchi, M, Locatelli, F, Rizzari, C, Biondi, A, Dander, E, D'Amico, G, Portale F, Cricrì G, Bresolin S, Lupi M, Gaspari S, Silvestri D, Russo B, Marino N, Ubezio P, Pagni F, Vergani P, Te Kronnie G, Valsecchi MG, Locatelli F, Rizzari C, Biondi A, Dander E, and D'Amico G.
- Abstract
B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the stromal microenvironment. New therapies targeting the interplay between leukemia and stroma can help improve disease outcome. We identified ActivinA, a TGF-b family member with a well-described role in promoting several solid malignancies, as a factor favoring leukemia that could represent a new potential target for therapy. ActivinA resulted over-expressed in the leukemic BM and its production was strongly induced in mesenchymal stromal cells after culture with leukemic cells. Moreover, MSCs isolated from BM of leukemic patients showed an intrinsic ability to secrete higher amounts of ActivinA compared to their normal counterparts. The pro-inflammatory leukemic BM microenvironment synergized with leukemic cells to induce stromal-derived ActivinA. Gene expression analysis of ActivinA-treated leukemic cells showed that this protein was able to significantly influence motility-associated pathways. Interestingly, ActivinA promoted random motility and CXCL12-driven migration of leukemic cells, even at suboptimal chemokine concentrations, characterizing the leukemic niche. Conversely, ActivinA severely impaired CXCL12-induced migration of healthy CD34 + cells. This opposite effect can be explained by the ability of ActivinA to increase intracellular calcium only in leukemic cells, boosting cytoskeleton dynamics through a higher rate of actin polymerization. Moreover, by stimulating the invasiveness of the leukemic cells, ActivinA was found to be a leukemia-promoting factor. Importantly, the ability of ActivinA to enhance BM engraftment and the metastatic potential of leukemic cells was confirmed in a xenograft mouse model of the disease. Overall, ActivinA was seen to be a key factor in conferring a migratory advantage to leukemic cells over healthy hematopoiesis within the leukemic niche.
- Published
- 2019
5. Flow injection flame atomic absorption determination of Cu, Mn and Zn partitioning in seawater by on-line room temperature sonolysis and minicolumn chelating resin methodology
- Author
-
Yebra-Biurrun, M.C. and Carro-Mariño, N.
- Published
- 2010
- Full Text
- View/download PDF
6. Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study
- Author
-
Fasano, M., Saracino, A., Carosi, G., Mazzotta, F., Marino, N., Sagnelli, E., Gaeta, G. B., Angarano, G., Verucchi, G., Bellissima, P., Angeletti, C., and Santantonio, T.
- Published
- 2013
- Full Text
- View/download PDF
7. Sport safety in school.
- Author
-
Marino, N.
- Published
- 2004
8. Training Simulators for Gastrointestinal Endoscopy: Current and Future Perspectives
- Author
-
Finocchiaro M, Cortegoso Valdivia P, Hernansanz A, Marino N, Amram D, Casals-Gelpi A, Menciassi A, Marlicz W, Ciuti G, and Koulaouzidis A
- Subjects
gastroscopy ,training ,colonoscopy ,simulators ,GI endoscopy ,medical simulation ,medical education - Abstract
Gastrointestinal (GI) endoscopy is the gold standard in the detection and treatment of early and advanced GI cancers. However, conventional endoscopic techniques are technically demanding and require visual-spatial skills and significant hands-on experience. GI endoscopy simulators represent a valid solution to allow doctors to practice in a pre-clinical scenario. From the first endoscopy mannequin, developed in 1969, several simulation platforms have been developed, ranging from purely mechanical systems to more complex mechatronic devices and animal-based models. Considering the recent advancement of technologies (e.g., artificial intelligence, augmented reality, robotics), simulation platforms can now reach high levels of realism, representing a valid and smart alternative to standard trainee/mentor learning programs. This is particularly true nowadays, when the current demographic trend and the most recent pandemic demand, more than ever, the ability to cope with many patients. This review offers a broad view of the technology available for GI endoscopy training, including platforms currently in the market and the relevant advancements in this research and application field. Additionally, new training needs and new emerging technologies are discussed to understand where medical education is heading.
- Published
- 2021
9. Publisher Correction: Hierarchical organization of perylene bisimides and polyoxometalates for photo-assisted water oxidation (Nature Chemistry, (2019), 11, 2, (146-153), 10.1038/s41557-018-0172-y)
- Author
-
Bonchio, M., Syrgiannis, Z., Burian, M., Marino, N., Pizzolato, E., Dirian, K., Rigodanza, F., Volpato, G. A., La Ganga, G., Demitri, N., Berardi, S., Amenitsch, H., Guldi, D. M., Caramori, S., Bignozzi, C. A., Sartorel, A., Prato, M., Bonchio, M., Syrgiannis, Z., Burian, M., Marino, N., Pizzolato, E., Dirian, K., Rigodanza, F., Volpato, G. A., La Ganga, G., Demitri, N., Berardi, S., Amenitsch, H., Guldi, D. M., Caramori, S., Bignozzi, C. A., Sartorel, A., and Prato, M.
- Subjects
water oxidation ,polyoxometalate ,perylene bisimides ,perylene bisimides, polyoxometalate, water oxidation - Abstract
The oxygen in Earth’s atmosphere is there primarily because of water oxidation performed by photosynthetic organisms using solar light and one specialized protein complex, photosystem II (PSII). High-resolution imaging of the PSII ‘core’ complex shows the ideal co-localization of multi-chromophore light-harvesting antennas with the functional reaction centre. Man-made systems are still far from replicating the complexity of PSII, as the majority of PSII mimetics have been limited to photocatalytic dyads based on a 1:1 ratio of a light absorber, generally a Ru–polypyridine complex, with a water oxidation catalyst. Here we report the self-assembly of multi-perylene-bisimide chromophores (PBI) shaped to function by interaction with a polyoxometalate water-oxidation catalyst (Ru4POM). The resulting [PBI]5Ru4POM complex shows a robust amphiphilic structure and dynamic aggregation into large two-dimensional paracrystalline domains, a redshifted light-harvesting efficiency of >40% and favourable exciton accumulation, with a peak quantum efficiency using ‘green’ photons (λ > 500 nm). The modularity of the building blocks and the simplicity of the non-covalent chemistry offer opportunities for innovation in artificial photosynthesis.
- Published
- 2019
10. AB0716 FIBROMYALGIA SYNDROME SEVERITY ACCORDING TO AGE CATEGORIES: RESULTS FROM A NATIONAL REGISTER
- Author
-
Di Carlo, M., primary, Farah, S., additional, Bazzichi, L., additional, Atzeni, F., additional, Govoni, M., additional, Biasi, G., additional, DI Franco, M., additional, Mozzani, F., additional, Gremese, E., additional, Dagna, L., additional, Batticciotto, A., additional, Fischetti, F., additional, Giacomelli, R., additional, Guiducci, S., additional, Guggino, G., additional, Bentivegna, M., additional, Gerli, R., additional, Salvarani, C., additional, Bajocchi, G., additional, Ghini, M., additional, Iannone, F., additional, Giorgi, V., additional, Cirillo, M., additional, Bonazza, S., additional, Barbagli, S., additional, Gioia, C., additional, Marino, N. G., additional, Capacci, A., additional, Cavalli, G., additional, Cappelli, A., additional, Carubbi, F., additional, Nacci, F., additional, Ilenia, R., additional, Cutolo, M., additional, Sinigaglia, L., additional, Sarzi-Puttini, P., additional, and Salaffi, F., additional
- Published
- 2021
- Full Text
- View/download PDF
11. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015
- Author
-
Quiros-Roldan, E, Magro, P, Raffetti, E, Izzo, I, Borghetti, A, Lombardi, F, Saracino, A, Maggiolo, F, Castelli, F, Carosi, G, Paraninfo, G, Torti, C, Cauda, R, Di Giambenedetto, S, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Di Pietro, M, Ble, C, Vichi, F, Sighinolfi, L, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Lapadula, G, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Quiros-Roldan E., Magro P., Raffetti E., Izzo I., Borghetti A., Lombardi F., Saracino A., Maggiolo F., Castelli F., Carosi G., Paraninfo G. E., Torti C., Cauda R., Di Giambenedetto S., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Di Pietro M., Ble C., Vichi F., Sighinolfi L., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Lapadula G., Puoti M., Viale P., Colangeli V., Borderi M., Quiros-Roldan, E, Magro, P, Raffetti, E, Izzo, I, Borghetti, A, Lombardi, F, Saracino, A, Maggiolo, F, Castelli, F, Carosi, G, Paraninfo, G, Torti, C, Cauda, R, Di Giambenedetto, S, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Di Pietro, M, Ble, C, Vichi, F, Sighinolfi, L, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Lapadula, G, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Quiros-Roldan E., Magro P., Raffetti E., Izzo I., Borghetti A., Lombardi F., Saracino A., Maggiolo F., Castelli F., Carosi G., Paraninfo G. E., Torti C., Cauda R., Di Giambenedetto S., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Di Pietro M., Ble C., Vichi F., Sighinolfi L., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Lapadula G., Puoti M., Viale P., Colangeli V., and Borderi M.
- Abstract
Background: Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of biochemical and inflammatory indices in patients switching to dual therapy (DT). Methods: We included patients that a) switched to a DT from 2007 to 2015 from a tenofovir/abacavir-based triple regimen b) previously maintained a triple and c) subsequently a dual regimen for 12 months with virological suppression. We retrieved data measured at 5 points (at the switch, 6 and 12 months before and after switch). We used platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and CD4/CD8 ratio as inflammatory indices. We assessed temporal trends of viro-immunological, biochemical and inflammatory parameters. Results: Overall, 364 and 65 patients switched from a tenofovir- and an abacavir-triple regimen, respectively. In the tenofovir-reducing group, creatinine clearance and lipids raised after the switch. There was a significant increase in both CD4+ cells and CD4/CD8. CD8+ cells rose after the switch, while opposite trend was found for PLR. In the abacavir-reducing group total lipids showed a decrease during the first 6 months after the switch and then stabilized. An increase of CD4+ and a decrease of CD8+ cells was observed during the study period, although not statistically significant. While CD4/CD8 remained stable after simplification, PLR decreased significantly after 6 months, then returning to baseline. CD8+ cells increased in the tenofovir-reducing group despite a viro-immunological response. Intriguingly, PLR decreased, maintaining this trend for 12 and 6 months after tenofovir and abacavir interruption respectively. Conclusions: Increased PLR has been linked to hypercholesterolemia and metabolic-syndrome, while high CD8+ cells count to increased risk of non-AIDS-related events regardless of CD4 T-cell re
- Published
- 2018
12. In situ resistance, not immigration, supports invertebrate community resilience to drought intensification in a Neotropical ecosystem
- Author
-
Bonhomme, C., Cereghino, R., Carrias, J. F., Compin, A., Corbara, B., Jassey, V. E. J., Leflaive, J., Farjalla, V. F., Marino, N. A. C., Rota, T., Srivastava, D. S., and Leroy, Céline
- Subjects
resistance ,functional ,climate change ,traits ,freshwater ecosystems ,fungi ,food and beverages ,community ,drought ,invertebrates ,resilience - Abstract
While future climate scenarios predict declines in precipitations in many regions of the world, little is known of the mechanisms underlying community resilience to prolonged dry seasons, especially in 'naive' Neotropical rainforests. Predictions of community resilience to intensifying drought are complicated by the fact that the underlying mechanisms are mediated by species' tolerance and resistance traits, as well as rescue through dispersal from source patches. We examined the contribution of in situ tolerance-resistance and immigration to community resilience, following drought events that ranged from the ambient norm to IPCC scenarios and extreme events. We used rainshelters above rainwater-filled bromeliads of French Guiana to emulate a gradient of drought intensity (from 1 to 3.6 times the current number of consecutive days without rainfall), and we analysed the post-drought dynamics of the taxonomic and functional community structure of aquatic invertebrates to these treatments when immigration is excluded (by netting bromeliads) or permitted (no nets). Drought intensity negatively affected invertebrate community resistance, but had a positive influence on community recovery during the post-drought phase. After droughts of 1 to 1.4 times the current intensities, the overall invertebrate abundance recovered within invertebrate life cycle durations (up to 2 months). Shifts in taxonomic composition were more important after longer droughts, but overall, community composition showed recovery towards baseline states. The non-random patterns of changes in functional community structure indicated that deterministic processes like environmental filtering of traits drive community re-assembly patterns after a drought event. Community resilience mostly relied on in situ tolerance-resistance traits. A rescue effect of immigration after a drought event was weak and mostly apparent under extreme droughts. Under climate change scenarios of drought intensification in Neotropical regions, community and ecosystem resilience could primarily depend on the persistence of suitable habitats and on the resistance traits of species, while metacommunity dynamics could make a minor contribution to ecosystem recovery. Climate change adaptation should thus aim at identifying and preserving local conditions that foster in situ resistance and the buffering effects of habitat features.
- Published
- 2020
13. Full characterization of the loading of a magneto–optical trap from an alkali metal dispenser
- Author
-
Bartalini, S., Herrera, I., Consolino, L., Pappalardo, L., Marino, N., D'Arrigo, G., and Cataliotti, F. S.
- Published
- 2005
- Full Text
- View/download PDF
14. Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy
- Author
-
Antonucci, G., Mazzotta, F., Puoti, M., Angeletti, C., Girardi, E., Santantonio, T., Ambu, S., Gaeta, G. B., Colucci, M., Angarano, G., Marino, N., Rinaldi, R., Bellissima, P., Armignacco, O., Carosi, G., and Sagnelli, E.
- Published
- 2012
- Full Text
- View/download PDF
15. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015
- Author
-
Quiros-Roldan, E., Magro, P., Raffetti, E., Izzo, I., Borghetti, Alberto, Lombardi, Francesca, Saracino, A., Maggiolo, F., Castelli, F., Carosi, Giulia, Paraninfo, G. E., Torti, Carlo, Cauda, Roberto, Di Giambenedetto, Simona, Fabbiani, M., Colafigli, Manuela, Scalzini, A., Castelnuovo, F., El Hamad, I., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Di Pietro, Maria Luisa, Ble, C., Vichi, F., Sighinolfi, L., Angarano, G., Ladisa, N., Monno, L., Maggi, P., Pan, A., Costarelli, S., Gori, A., Lapadula, G., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Quiros-Roldan, E, Magro, P, Raffetti, E, Izzo, I, Borghetti, A, Lombardi, F, Saracino, A, Maggiolo, F, Castelli, F, Carosi, G, Paraninfo, G, Torti, C, Cauda, R, Di Giambenedetto, S, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Di Pietro, M, Ble, C, Vichi, F, Sighinolfi, L, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Lapadula, G, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Blè, C, and Border, M
- Subjects
0301 basic medicine ,Male ,HIV Infections ,Gastroenterology ,Cohort Studies ,0302 clinical medicine ,Abacavir ,Antiretroviral Therapy, Highly Active ,030212 general & internal medicine ,Darunavir ,virus diseases ,Switch ,Middle Aged ,Antiretroviral therapy ,Infectious Diseases ,Treatment Outcome ,Italy ,Reverse Transcriptase Inhibitors ,Female ,medicine.symptom ,medicine.drug ,Research Article ,Adult ,medicine.medical_specialty ,Anti-HIV Agents ,Dual-therapy ,HIV ,Inflammation ,Atazanavir Sulfate ,CD4-CD8 Ratio ,Renal function ,Settore MED/17 - MALATTIE INFETTIVE ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Immune system ,Internal medicine ,medicine ,Humans ,lcsh:RC109-216 ,Tenofovir ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Reverse transcriptase ,Dideoxynucleosides ,Regimen ,030104 developmental biology ,business ,CD8 - Abstract
Background Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of biochemical and inflammatory indices in patients switching to dual therapy (DT). Methods We included patients that a) switched to a DT from 2007 to 2015 from a tenofovir/abacavir-based triple regimen b) previously maintained a triple and c) subsequently a dual regimen for 12 months with virological suppression. We retrieved data measured at 5 points (at the switch, 6 and 12 months before and after switch). We used platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and CD4/CD8 ratio as inflammatory indices. We assessed temporal trends of viro-immunological, biochemical and inflammatory parameters. Results Overall, 364 and 65 patients switched from a tenofovir- and an abacavir-triple regimen, respectively. In the tenofovir-reducing group, creatinine clearance and lipids raised after the switch. There was a significant increase in both CD4+ cells and CD4/CD8. CD8+ cells rose after the switch, while opposite trend was found for PLR. In the abacavir-reducing group total lipids showed a decrease during the first 6 months after the switch and then stabilized. An increase of CD4+ and a decrease of CD8+ cells was observed during the study period, although not statistically significant. While CD4/CD8 remained stable after simplification, PLR decreased significantly after 6 months, then returning to baseline. CD8+ cells increased in the tenofovir-reducing group despite a viro-immunological response. Intriguingly, PLR decreased, maintaining this trend for 12 and 6 months after tenofovir and abacavir interruption respectively. Conclusions Increased PLR has been linked to hypercholesterolemia and metabolic-syndrome, while high CD8+ cells count to increased risk of non-AIDS-related events regardless of CD4 T-cell recovery and to virological failure. Whether these findings may have clinical implications, and which role DT plays on the immune system and on inflammation should be further investigated.
- Published
- 2018
16. Metal Pollution by Old Lead-Zinc Mines in Urumea River Valley (Basque Country, Spain). Soil, Biota and Sediment
- Author
-
Sánchez, J., Marino, N., Vaquero, M. C., Ansorena, J., and Legórburu, I.
- Published
- 1998
- Full Text
- View/download PDF
17. Use of PET/CT to detect local and regional laryngeal cancer recurrence after surgery
- Author
-
Allegra E, Saita V, De Natale M, Marino N, Trapasso S, Tamburrini S, Alessio C, and Ippolito M
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,PET/CT imaging ,lcsh:R895-920 ,laryngeal cancer ,local and regional laryngeal cancer recurrence - Abstract
Eugenia Allegra,1 Vincenzo Saita,2 Massimo De Natale,2 Nicolò Marino,2 Serena Trapasso,1 Stefania Tamburrini,3 Caterina Alessio,4 Massimo Ippolito5 1Otolaryngology, Department of Health Sciences, University of Catanzaro, Catanzaro, 2Department of Otolaryngology, Cannizzaro Hospital, Catania, 3Department of Radiology, Pellegrini Hospital, Naples, 4Department of Experimental and Clinical Medicine-Radiology, University of Catanzaro, Catanzaro, 5Department of Nuclear Medicine, Cannizzaro Hospital, Catania, Italy Background: Laryngeal cancer is the second most common cancer of the head and neck after cancer of the oral cavity. The primary causes of death in cases of laryngeal cancer are the recurrence of locoregional disease and distant metastasis. Anatomic and tissue alterations resulting from surgery and/or radiotherapy of primary laryngeal tumors can make it difficult to determine a locoregional recurrence or residual disease by physical examination or computed tomography (CT)/magnetic resonance imaging (MRI). The majority of studies have shown a high accuracy in the detection of local and regional recurrence of head and neck cancer after different treatment modalities, using fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT.Aim: To determine the diagnostic accuracy of PET/CT in patients with suspicion of locoregional recurrence from laryngeal carcinoma after surgery with or without adjuvant radiotherapy.Materials and methods: This was a retrospective study. Forty-five patients who previously underwent surgical treatment with or without adjuvant radiotherapy for primary laryngeal squamous cell carcinoma and who underwent examination using FDG-PET/CT imaging after clinical and instrumental (CT/MRI) suspicion of locoregional recurrence (T or N) were recruited.Results: Overall specificity, sensitivity, and accuracy of PET/CT were found to be 88%, 100%, and 93.3%, respectively. With respect to the suspected cases of recurrence in the primary site, sensitivity, specificity, and accuracy of PET/CT were found to be 100%, 87.5%, and 91.6%, respectively. In patients with suspected metastatic neck disease, PET/CT revealed a sensitivity, specificity, and accuracy of 100%, 90%, and 95.4%, respectively.Conclusion: According to the results of this study, PET/CT imaging in laryngeal tumors is a useful tool in case of suspected locoregional recurrence where conventional imaging (CT and MRI) is unable to resolve the diagnostic doubt. Keywords:laryngealcancer, PET/CT imaging, laryngeal cancer recurrence, laryngeal cancer PET/CT imaging
- Published
- 2017
18. Cardiopulmonary Conditions
- Author
-
MARINO, N, primary
- Published
- 2005
- Full Text
- View/download PDF
19. Serum Cystatin C as a Reliable Marker of Changes in Glomerular Filtration Rate in Children With Urinary Tract Malformations
- Author
-
Corrao, A. M., Lisi, G., Di Pasqua, G., Guizzardi, M., Marino, N., Ballone, E., and Chiesa, P. Lelli
- Published
- 2006
20. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
- Author
-
Portale, F., Cricri, G., Bresolin, S., Lupi, M., Gaspari, S., Silvestri, D., Russo, B., Marino, N., Ubezio, P., Pagni, F., Vergani, P., Te Kronnie, G., Valsecchi, M. G., Locatelli, Franco, Rizzari, C., Biondi, A., Dander, E., D'Amico, G., Locatelli F. (ORCID:0000-0002-7976-3654), Portale, F., Cricri, G., Bresolin, S., Lupi, M., Gaspari, S., Silvestri, D., Russo, B., Marino, N., Ubezio, P., Pagni, F., Vergani, P., Te Kronnie, G., Valsecchi, M. G., Locatelli, Franco, Rizzari, C., Biondi, A., Dander, E., D'Amico, G., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the stromal microenvironment. New therapies targeting the interplay between leukemia and stroma can help improve disease outcome. We identified ActivinA, a TGF-b family member with a well-described role in promoting several solid malignancies, as a factor favoring leukemia that could represent a new potential target for therapy. ActivinA resulted over-expressed in the leukemic BM and its production was strongly induced in mesenchymal stromal cells after culture with leukemic cells. Moreover, MSCs isolated from BM of leukemic patients showed an intrinsic ability to secrete higher amounts of ActivinA compared to their normal counterparts. The pro-inflammatory leukemic BM microenvironment synergized with leukemic cells to induce stromal-derived ActivinA. Gene expression analysis of ActivinA-treated leukemic cells showed that this protein was able to significantly influence motility-associated pathways. Interestingly, ActivinA promoted random motility and CXCL12-driven migration of leukemic cells, even at suboptimal chemokine concentrations, characterizing the leukemic niche. Conversely, ActivinA severely impaired CXCL12-induced migration of healthy CD34 + cells. This opposite effect can be explained by the ability of ActivinA to increase intracellular calcium only in leukemic cells, boosting cytoskeleton dynamics through a higher rate of actin polymerization. Moreover, by stimulating the invasiveness of the leukemic cells, ActivinA was found to be a leukemia-promoting factor. Importantly, the ability of ActivinA to enhance BM engraftment and the metastatic potential of leukemic cells was confirmed in a xenograft mouse model of the disease. Overall, ActivinA was seen to be a key factor in conferring a migratory advantage to leukemic cells over healthy hematopoiesis within the leukemic niche.
- Published
- 2019
21. Refluxing primary obstructive megaureter: diagnostic and therapeutic approach in 20 neonatal cases
- Author
-
ANDRIANI, M., FUSILLO, M., ILLICETO, M. T., CHIESA, P. LELLI, MARINO, N., and PERSICO, A.
- Published
- 2004
22. Excimer laser induced thermal evaporation and ablation of silicon carbide
- Author
-
Reitano, R., primary, Baeri, P., additional, and Marino, N., additional
- Published
- 1996
- Full Text
- View/download PDF
23. EARLY HCV-RNA CLEARANCE DURING DAILY ADMINISTRATION OF INTERFERON IN COMBINATION WITH RIBAVIRIN IN NAIVE HCV PATIENTS
- Author
-
Taliani, G., Badolato, M. C., Pasquazzi, C., Boddi, V., Gaeta, G. B., Stornaiuolo, G., Marino, N., Blanc, P. L., and De Bac, C.
- Published
- 2000
24. Exploratory analysis for the evaluation of estimated glomerular filtration rate, cholesterol and triglycerides after switching from tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r) to abacavir/lamivudine plus ATV/r in patients with preserved renal function
- Author
-
Postorino, M, Quiros-Roldan, E, Maggiolo, F, di Giambenedetto, S, Ladisa, N, Lapadula, G, Lorenzotti, S, Sighinolfi, L, Castelnuovo, F, di Pietro, M, Gotti, D, Mazzini, N, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Fabbiani, M, Colafigli, M, Scalzini, A, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Postorino M. C., Quiros-Roldan E., Maggiolo F., di Giambenedetto S., Ladisa N., Lapadula G., Lorenzotti S., Sighinolfi L., Castelnuovo F., di Pietro M., Gotti D., Mazzini N., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Fabbiani M., Colafigli M., Scalzini A., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Puoti M., Viale P., Colangeli V., Borderi M., Postorino, M, Quiros-Roldan, E, Maggiolo, F, di Giambenedetto, S, Ladisa, N, Lapadula, G, Lorenzotti, S, Sighinolfi, L, Castelnuovo, F, di Pietro, M, Gotti, D, Mazzini, N, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Fabbiani, M, Colafigli, M, Scalzini, A, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Postorino M. C., Quiros-Roldan E., Maggiolo F., di Giambenedetto S., Ladisa N., Lapadula G., Lorenzotti S., Sighinolfi L., Castelnuovo F., di Pietro M., Gotti D., Mazzini N., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Fabbiani M., Colafigli M., Scalzini A., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Puoti M., Viale P., Colangeli V., and Borderi M.
- Abstract
Background and Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by ritonavir, ATV/r) could perpetuate some degrees of renal impairment with or without TDF co-administration. Also, possible benefits of stopping TDF in patients without renal diseases is not well known. This study aimed at exploring evolution of renal function and lipid profile after switching from tenofovir/emtricitabine (TDF/FTC) to abacavir/lamivudine (ABC/3TC), maintaining the ATV/r component of the regimen. Methods: Patients in the Italian MASTER Cohort, who switched from TDF/FTC plus ATV/r to ABC/3TC plus ATV/r were included, provided that major renal diseases were not diagnosed before switching (i.e., baseline). Serum creatinine, estimated glomerular filtration rate (eGFR), total cholesterol, HDL and triglycerides were evaluated at baseline and at month 18 after switching. Results: 126 patients were selected (80% males). Patients were mostly Italians (92%). 79% had undetectable HIV-RNA and 44% were coinfected by HBV and/or HCV. Median age at switch was 47 years (IQR 43-55). A small but significant decrease in serum creatinine [from 1.06 mg/dl (SD: 0.3) to 0.94 mg/dl (SD: 0.2); p<0.001] with an improvement in eGFR [from 86.8 ml/min (SD: 33) to 96.4 ml/min (SD: 37); p<0.001] were observed in per protocol analysis at month 18. Also ITT analysis showed a decrease in mean serum creatinine [from 1.08 mg/dl (SD: 0.35) to 0.95 mg/dl (SD: 0.24); p<0.001] with an improvement in mean eGFR [from 86.9 ml/min/1.73m2 (SD: 24.11) to 95.8 ml/min/1.73m2 (SD: 19.99); p<0.001]. Total cholesterol increased [from 188 mg/dl (SD: 42) to 206 mg/dl (SD: 44); p<0.001] but also HDL increased as well [from 46 mg/dl (SD: 14) to 54 mg/dl (SD: 19); p=0.015]. An increase in triglycerides concentration was observed [from 162 mg/dl (SD: 144) to 214 mg/dl (SD: 109); p=0.0
- Published
- 2016
25. RIBAVIRIN AND α-INTERFERON COMBINATION THERAPY IN THE RETREATMENT OF CHRONIC HEPATITIS C IN TUSCANY (ITALY)
- Author
-
Nerli, A., Ambu, S., Chimenti, M., Esperti, F., Gonnelli, A., Marino, N., Messina, F., Riccardi, M. P., and Tacconi, D.
- Published
- 1999
26. Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART
- Author
-
LAPADULA, GIUSEPPE, GORI, ANDREA, Chatenoud, L, Castelli, F, Di Giambenedetto, S, Fabbiani, M, Maggiolo, F, Focà, E, Ladisa, N, Sighinolfi, L, Di Pietro, M, Pan, A, Torti, C, Carosi, G, Quiros, E, Nasta, P, Paraninfo, G, Cauda, R, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Pierotti, P, Marino, N, Blè, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Costarelli, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M., Lapadula, G, Chatenoud, L, Gori, A, Castelli, F, Di Giambenedetto, S, Fabbiani, M, Maggiolo, F, Focà, E, Ladisa, N, Sighinolfi, L, Di Pietro, M, Pan, A, Torti, C, Carosi, G, Quiros, E, Nasta, P, Paraninfo, G, Cauda, R, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Pierotti, P, Marino, N, Blè, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Costarelli, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Lapadula, G., Chatenoud, L., Gori, A., Castelli, F., Di Giambenedetto, S., Fabbiani, M., Maggiolo, F., Foca, E., Ladisa, N., Sighinolfi, L., Di Pietro, M., Pan, A., Torti, C., Carosi, G., Quiros, E., Nasta, P., Paraninfo, G., Cauda, R., Colafigli, M., Scalzini, A., Castelnuovo, F., El Hamad, I., Mazzotta, F., Locaputo, S., Pierotti, P., Marino, N., Ble, C., Vichi, F., Angarano, G., Monno, L., Maggi, P., Costarelli, S., Puoti, M., Viale, P., Colangeli, V., and Borderi, M.
- Subjects
Male ,Comorbidity ,medicine.disease_cause ,Risk Factors ,Neoplasms ,Antiretroviral Therapy, Highly Active ,Cardiovascular Disease ,education.field_of_study ,Multidisciplinary ,Coinfection ,Incidence (epidemiology) ,Liver Diseases ,Liver Disease ,Medicine (all) ,Hepatitis C ,Middle Aged ,Viral Load ,Cardiovascular Diseases ,Disease Progression ,Medicine ,Female ,Viral load ,Research Article ,Human ,Adult ,medicine.medical_specialty ,Science ,Hepatitis C virus ,Population ,Antiretroviral Therapy ,Settore MED/17 - MALATTIE INFETTIVE ,Acquired immunodeficiency syndrome (AIDS) ,Internal medicine ,medicine ,Humans ,Highly Active ,education ,Acquired Immunodeficiency Syndrome ,Biochemistry, Genetics and Molecular Biology (all) ,business.industry ,Risk Factor ,medicine.disease ,CD4 Lymphocyte Count ,cd4 ,Agricultural and Biological Sciences (all) ,Immunology ,Neoplasm ,business - Abstract
Background: Immunological non-response (INR) despite virological suppression is associated with AIDS-defining events/death (ADE). Little is known about its association with serious non-AIDS-defining events (nADE). Methods Patients highly-active antiretroviral therapy (HAART) with 50. Results: 1221 patients were observed for a median of 3 (IQR: 1.3-6.1) years. Pre-HAART CD4+were 77/μl (IQR: 28-142) and 56% of patients had experienced an ADE. After 1 year, CD4+ increased to 286 (IQR: 197-387), but 26.1% of patients were INR. Thereafter, 86 nADE (30.2% malignancies, 27.9%infectious, 17.4%renal, 17.4Êrdiovascular, 7% hepatic) were observed, accounting for an incidence of 1.83 events (95%CI: 1.73-2.61) per 100 PYFU. After adjusting for measurable confounders, INR had a significantly greater risk of nADE (HR 1.65; 95%CI: 1.06-2.56). Older age (per year, HR 1.03; 95%CI: 1.01-1.05), hepatitis C co-infection (HR 2.09; 95%CI: 1.19-3.7), a history of previous nADE (HR 2.16; 95% CI: 1.06-4.4) and the occurrence of ADE during the follow-up (HR 2.2; 95%CI: 1.15-4.21) were other independent predictors of newly diagnosed nADE. Conclusions: Patients failing to restore CD4+ to >200 cells/μl run a greater risk of serious nADE, which is intertwined or predicted by AIDS progression. Improved management of this fragile population and innovative therapy able to induce immune-reconstitution are urgently needed. Also, our results strengthen the importance of earlier diagnosis and HAART introduction.
- Published
- 2015
27. Functional traits and environmental conditions predict community isotopic niches and energy pathways across spatial scales
- Author
-
Dézerald, O., Srivastava, D. S., Céréghino, R., Carrias, J. F., Corbara, B., Farjalla, V. F., Leroy, Céline, Marino, N. A. C., Piccoli, G. C. O., Richardson, B. A., Richardson, M. J., Romero, G. Q., and Gonzalez, A. L.
- Subjects
functional biogeography ,metacommunity ,food webs ,trophic structure ,environmental heterogeneity ,functional diversity ,isotopic niche ,energy pathways - Abstract
1. Despite ongoing research in food web ecology and functional biogeography, the links between food web structure, functional traits and environmental conditions across spatial scales remain poorly understood. Trophic niches, defined as the amount of energy and elemental space occupied by species and food webs, may help bridge this divide. 2. Here, we ask how the functional traits of species, the environmental conditions of habitats and the spatial scale of analysis jointly determine the characteristics of trophic niches. We used isotopic niches as a proxy of trophic niches, and conducted analyses at spatial scales ranging from local food webs and metacommunities to geographically distant sites. 3. We sampled aquatic macroinvertebrates from 104 tank bromeliads distributed across five sites from Central to South America and compiled the macroinvertebrates' functional traits and stable isotope values (delta N-15 and delta C-13). We assessed how isotopic niches within each bromeliad were influenced by the functional trait composition of their associated invertebrates and environmental conditions (i.e., habitat size, canopy cover [CC] and detrital concentration [DC]). We then evaluated whether the diet of dominant predators and, consequently, energy pathways within food webs reflected functional and environmental changes among bromeliads across sites. At last, we determined the extent to which the isotopic niches of macroinvertebrates within each bromeliad contributed to the metacommunity isotopic niches within each site and compared these metacommunity-level niches over biogeographic scales. 4. At the bromeliad level, isotopic niches increased with the functional richness of species in the food web and the DC in the bromeliad. The diet of top predators tracked shifts in prey biomass along gradients of CC and DC. Bromeliads that grew under heterogeneous CC displayed less trophic redundancy and therefore combined to form larger metacommunity isotopic niches. At last, the size of metacommunity niches depended on within-site heterogeneity in CC. 5. Our results suggest that the trophic niches occupied by food webs can predictably scale from local food webs to metacommunities to biogeographic regions. This scaling process is determined by both the functional traits of species and heterogeneity in environmental conditions.
- Published
- 2018
28. Confined photo-release of nitric oxide with simultaneous two-photon fluorescence tracking in a cellular system
- Author
-
Thomsen, H., Marino, N., Conoci, S., Sortino, S., and Ericson, M. B.
- Subjects
Photons ,Microscopy, Confocal ,Ultraviolet Rays ,Synthase, Nitric oxide, Cell line ,lcsh:R ,lcsh:Medicine ,Nitric Oxide ,Synthase ,Fluorescence ,Article ,Cell Line ,Humans ,lcsh:Q ,lcsh:Science - Abstract
Nitric oxide (NO) is a key signaling molecule in biological systems. New tools are required to therapeutically modulate NO levels with confined precision. This study explores the photoactivatable properties of an NO releasing compound (CPA), based on cupferron O-alkylated with an anthracene derivative. Upon light stimulation, CPA uncages two species: cupferron, which liberates NO, and an anthrylmethyl carbocation, which evolves into a fluorescent reporter. Proof-of-principle is demonstrated using one- and two-photon excitation (1PE and 2PE) in a cellular system (A431 cells). It was found that 1PE induces cell toxicity, while 2PE does not. Since 1PE using UV light is more likely to generate cellular photodamage, the cell toxicity observed using 1PE is most likely a combinatory effect of NO release and other UV-induced damage, which should be subject to further investigation. On the other hand, absence of phototoxicity using 2PE suggests that NO alone is not cytotoxic. This leads to the conclusion that the concept of 2PE photorelease of NO from CPA enable opportunities for biological studies of NO signaling with confined precision of NO release with minimal cytotoxicity.
- Published
- 2018
29. Exploratory analysis for the evaluation of estimated glomerular filtration rate, cholesterol and triglycerides after switching from tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r) to abacavir/lamivudine plus ATV/r in patients with preserved renal function
- Author
-
Postorino, Maria Concetta, Quiros Roldan, Eugenia, Maggiolo, Franco, Di Giambenedetto, Simona, Ladisa, Nicoletta, Lapadula, Giuseppe, Lorenzotti, Silvia, Sighinolfi, Laura, Castelnuovo, Filippo, di Pietro, Massimo, Gotti, Daria, Mazzini, Nicola, Torti, Carlo, Castelli, F., Carosi, G., Nasta, P., Paraninfo, G., Focà, E., di Giambenedetto, R. Cauda S., Fabbiani, Massimiliano, Colafigli, Manuela, Scalzini, A., El Hamad, I., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Monno, L., Maggi, P., Pan, A., Costarelli, S., Gori, A., Lapadula, G., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Postorino, M, Quiros-Roldan, E, Maggiolo, F, di Giambenedetto, S, Ladisa, N, Lapadula, G, Lorenzotti, S, Sighinolfi, L, Castelnuovo, F, di Pietro, M, Gotti, D, Mazzini, N, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Fabbiani, M, Colafigli, M, Scalzini, A, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Puoti, M, Viale, P, Colangeli, V, and Borderi, M
- Subjects
0301 basic medicine ,Atazanavir ,Cholesterol ,eGFR ,Highly active antiretroviral therapy ,Nephrotoxicity ,Tenofovir ,Public Health, Environmental and Occupational Health ,Infectious Diseases ,Virology ,medicine.medical_specialty ,Urology ,Renal function ,Pharmacology ,Emtricitabine ,Settore MED/17 - MALATTIE INFETTIVE ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Abacavir ,medicine ,Creatinine ,business.industry ,Highly Active Antiretroviral Therapy ,Environmental and Occupational Health ,Lamivudine ,Abacavir/Lamivudine ,030112 virology ,chemistry ,Ritonavir ,Public Health ,business ,medicine.drug - Abstract
Background and Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by ritonavir, ATV/r) could perpetuate some degrees of renal impairment with or without TDF co-administration. Also, possible benefits of stopping TDF in patients without renal diseases is not well known. This study aimed at exploring evolution of renal function and lipid profile after switching from tenofovir/emtricitabine (TDF/FTC) to abacavir/lamivudine (ABC/3TC), maintaining the ATV/r component of the regimen. Methods: Patients in the Italian MASTER Cohort, who switched from TDF/FTC plus ATV/r to ABC/3TC plus ATV/r were included, provided that major renal diseases were not diagnosed before switching (i.e., baseline). Serum creatinine, estimated glomerular filtration rate (eGFR), total cholesterol, HDL and triglycerides were evaluated at baseline and at month 18 after switching. Results: 126 patients were selected (80% males). Patients were mostly Italians (92%). 79% had undetectable HIV-RNA and 44% were coinfected by HBV and/or HCV. Median age at switch was 47 years (IQR 43-55). A small but significant decrease in serum creatinine [from 1.06 mg/dl (SD: 0.3) to 0.94 mg/dl (SD: 0.2); p
- Published
- 2016
30. Flow Cytometric Measurement of the Initial In Vivo Response to Prednisone Provides New Prognostic Information in Childhood Acute Lymphoblastic Leukemia (ALL)
- Author
-
Gaipa, G, Maglia, O, Sala, S, Marino, N, Silvestri, D, Valsecchi, M, Biondi, A, Conter, V, Gaipa, Giuseppe, Maglia, Oscar, Sala, Simona, Marino, Noemi, Silvestri, Daniela, Valsecchi, Maria Grazia, Biondi, Andrea, Conter, Valentino, Gaipa, G, Maglia, O, Sala, S, Marino, N, Silvestri, D, Valsecchi, M, Biondi, A, Conter, V, Gaipa, Giuseppe, Maglia, Oscar, Sala, Simona, Marino, Noemi, Silvestri, Daniela, Valsecchi, Maria Grazia, Biondi, Andrea, and Conter, Valentino
- Abstract
Background The initial in vivo response on corticosteroid therapy (<1000 blasts/mmc at day 8 after exposure to Prednisone) is considered a prognostic predictor to qualify patients at higher risk of relapse (Riehm H et al, Klin. Padiat. 199, 1986). This parameter has been prospectively validated in several BFM-oriented trials providing evidences to be a robust predictor of disease recurrence even in specific subgroups of ALL (Schrappe M et al, Klin. Padiat. 2013). Evaluation of day8 prednisone response is assessed by morphological evaluation of peripheral blood (PB) smears, however this approach may have several limitations such as poor quality of the smears, operator- dependent variability and accuracy, poor reproducibility between centers. Methods We studied a total of 543 (of 648 eligible) patients enrolled in the AIEOP-BFM ALL 2000 study between January 2001 and December 2011 in the centers of Monza and Padova (275 and 268 patients respectively). PB collected at day+8 of induction phase was analyzed by multiparametric flow cytometry (FCM) to assess blast immunophenotyping by standard methods developed in the context of the I-BFM Flow network (Dworzak MN et al, Cytometry part B, 2008). Results Five hundred-seven patients (93.4%) had <1000 blasts/mmc as assessed by FCM, whereas 36 (6.6%) had ≥1000 blasts/mmc. Five-year Event Free Survival (5 yrs EFS) was 84.8% and 76.4% respectively (p-value =0.01). We further investigated the absolute count by sub-grouping the patients in three levels: i) 0<100 blasts/mmc (n 416), ii) ≥100<1000 blasts/mmc (n 91), and iii) ≥ 1000 blasts/mmc (n 36). 5 yrs EFS was 86.8%, 75.6% and 76.4%, respectively (p-value group a vs group b was 0.001), see Figure. Five years Cumulative Incidence of Relapse (5yrs CIR) was 11.4%, 21.1% and 17.9%, respectively (p-value group a vs group b was 0.003). When we excluded the high-risk (HR) patients from the analysis, those in the group with ≥100<1000 blasts/mmc (n71) maintained a significa
- Published
- 2018
31. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort
- Author
-
Postorino, M, Prosperi, M, Quiros-Roldan, E, Maggiolo, F, Di Giambenedetto, S, Saracino, A, Costarelli, S, Lorenzotti, S, Sighinolfi, L, Di Pietro, M, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Cauda, R, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Gori, A, Lapadula, G, Ospedale, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Policlinico, S, Postorino M. C., Prosperi M., Quiros-Roldan E., Maggiolo F., Di Giambenedetto S., Saracino A., Costarelli S., Lorenzotti S., Sighinolfi L., Di Pietro M., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Cauda R., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Gori A., Lapadula G., Ospedale S., Puoti M., Viale P., Colangeli V., Borderi M., Policlinico S., Postorino, M, Prosperi, M, Quiros-Roldan, E, Maggiolo, F, Di Giambenedetto, S, Saracino, A, Costarelli, S, Lorenzotti, S, Sighinolfi, L, Di Pietro, M, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Cauda, R, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Gori, A, Lapadula, G, Ospedale, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Policlinico, S, Postorino M. C., Prosperi M., Quiros-Roldan E., Maggiolo F., Di Giambenedetto S., Saracino A., Costarelli S., Lorenzotti S., Sighinolfi L., Di Pietro M., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Cauda R., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Gori A., Lapadula G., Ospedale S., Puoti M., Viale P., Colangeli V., Borderi M., and Policlinico S.
- Abstract
Randomized trials and observational cohorts reported higher rates of virological suppression after highly active antiretroviral therapy (HAART) including efavirenz (EFV), compared with boosted protease inhibitors (PIs). Correlations with immunological and clinical outcomes are unclear. Patients of the Italian MASTER cohort who started HAART from 2000 to 2010 were selected. Outstanding outcome (composite outcome for success (COS)) was introduced. We evaluated predictors of COS (no AIDS plus CD4+ count >500/mm3 plus HIV-RNA <500 copies/mL) and of eight single outcomes either at month 6 or at year 3. Multivariable logistic regression was conducted. There were 6259 patients selected. Patients on EFV (43%) were younger, had greater CD4+ count, presented with AIDS less frequently, and more were Italians. At year 3, 90% of patients had HIV RNA <500 copies/mL, but only 41.4% were prescribed EFV, vs. 34.1% prescribed boosted PIs achieved COS (p <0.0001). At multivariable analysis, patients on lopinavir/ritonavir had an odds ratio of 0.70 for COS at year 3 (p <0.0001). Foreign origin and positive hepatitis C virus-Ab were independently associated with worse outcome (OR 0.54, p <0.0001 and OR 0.70, p 0.01, respectively). Patients on boosted PIs developed AIDS more frequently either at month 6 (13.8% vs. 7.6%, p <0.0001) or at year 3 (17.1% vs. 13.8%, p <0.0001). At year 3, deaths of patients starting EFV were 3%, vs. 5% on boosted PIs (p 0.008). In this study, naïve patients on EFV performed better than those on boosted PIs after adjustment for imbalances at baseline. Even when virological control is achieved, COS is relatively rare. Hepatitis C virus-positive patients and those of foreign origin are at risk of not obtaining COS.
- Published
- 2015
32. ANALISIS FINGERPRINT DAUN GEDI HIJAU (Abelmoschus manihot L) UNTUK MEMPREDIKSI AKTIVITAS ANTIOKSIDAN MENGGUNAKAN KOMBINASI SPEKTROSKOPI IR DENGAN PARTIAL LEAST SQUAREREGRESSION
- Author
-
Warongan, Marino N.
- Abstract
ANALISIS FINGERPRINT DAUN GEDI HIJAU (Abelmoschus manihot L) UNTUK MEMPREDIKSI AKTIVITAS ANTIOKSIDAN MENGGUNAKAN KOMBINASI SPEKTROSKOPI IR DENGAN PARTIALLEAST SQUAREREGRESSION Marino Novri Warongan1), Sri Sudewi1), Adithya Yudistira1)1)Program Studi Farmasi FMIPA UNSRAT Manado, 95115 ABSTRACT The study aims to determine the antioxidant activity, infrared spectra and correlation between spectral data and antioxidant activity of green gedi leaves. Method of determining prediction of antioxidant activity through fingerprint analysis using combination of IR spectroscopy and Chemometric Partial Least Square Regression (PLSR). DPPH method is used to prevent free radical and free-radical yield of free radical or concentration 150 ppm Bitung A sample 91.392 ± 1.125, Bitung B sample 88.493 ± 1.515 dan Bitung C sample 91.663 ± 1.184, Manado A sample 89.464 ± 1.642, Manado B sample 90.096 ± 3.510, and Manado C sample 89.477 ± 0.850, and in the Kotamobagu sample A 86.678 ± 3.703, Kotamobagu sample B 82.963 ± 2.991 and Kotamobagu sample C 83.163 ± 6.354. Gedi leaves from the city of Bitung, Manado, and Kotamobagu has a relatively similar spectrum. This combination involves the FTIR spectrum as the “x” variabel and the result data of the DPPH method as the “y” variabel. The prediction model can be used because it has error value ( standar error calibration (SEC = 0.0615), standard error of prediction (SEP = 0.0763)) and calibration value of 0.4181, and r validation of 0.2917. Keywords: Antioxidant, Green Gedi Leaves, FTIR Spectrophotometry, UV-VIS Spectrophotometry, Chemometric . ABSTRAK Penelitian ini bertujuan untuk mengetahui aktivitas antioksidan, spektrum infra merah dan korelasi antara data spektrum dan aktivitas antioksidan daun gedi hijau. Metode penentuan prediksi aktivitas antioksidan melaui analisis fingerprint menggunakan kombinasi Spektroskopi IR dan Kemometrik Partial Least Square Regression (PLSR). Metode DPPH digunakan untuk menangkal radikal bebas dan hasil persen penangkal radikal bebas pada konsentrasi 150 ppm Sampel Bitung A 91.392 ± 1.125, Sampel Bitung B 88.493 ± 1.515 dan Sampel Bitung C 91.663 ± 1.184, Sampel Manado A 89.464 ± 1.642, Sampel Manado B 90.096 ± 3.510, dan Sampel Manado C 89.477 ± 0.850, dan terakir pada Sampel Kotamobagu A 86.678 ± 3.703, Sampel Kotamobagu B 82.963 ± 2.991 dan Sampel Kotamobagu C 83.163 ± 6.354.Daun Gedi dari kota Bitung, Manado dan Kotamobagu ini memiliki spektrum yang relatif sama. Kombinasi ini melibatkan dari spektrum FTIR sebagai variabelx dan data hasil analisis metode DPPH sebagai variabely. Model prediksi dapat digunakan karena memiliki nilai kesalahan (standar error calibration (SEC = 0.0615), standard error of prediction (SEP = 0.0763)) dan nilai r kalibrasi 0.4181, serta r validasi 0.2917. Kata Kunci : Antioksidan, Daun Gedi Hijau, Spektrofotometri FTIR, Spektrofotometri UV-VIS, Kemometrik.
- Published
- 2017
33. Is remote live urologic surgery a reality? Evidences from a systematic review of the literature.
- Author
-
Veneziano, Domenico, Tafuri, A., Rivas, J. Gomez, Dourado, A., Okhunov, Z., Somani, B. K., Marino, N., Fuchs, G., and Cacciamani, G.
- Subjects
MINIMALLY invasive procedures ,META-analysis ,APPROPRIATE technology ,WEB databases ,UROLOGICAL surgery - Abstract
Introduction and objectives: The possibility of performing remote-surgery has been the goal to achieve, since the early development of the first surgical robotic platforms. This systematic review aims to analyse the state of the art in the field and to provide an overview of the possible growth of this technology. Methods: All English language publications on Telementoring and Telesurgery for minimally invasive urologic procedures were evaluated. We followed the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) statement to evaluate PubMed
® , Scopus® , and Web of Science™ databases (up to June 2019). Results: Our electronic search identified a total of 124 papers in PubMed, Scopus, and Web of Science. Of these, 81 publications were identified for detailed review, which yielded 22 included in the present systematic review. Our results showed that remote surgery has been under-utilised until today, mostly due to the lack of appropriate telecommunication technologies. Conclusion: Remote live surgery is a growing technology that is catalyzing incremental interest. Despite not being yet reliable today on a regular basis in its most advanced applications, thanks to the advent of novel data-transmission technologies, telepresence might become a critical educational methodology, highly impacting the global healthcare system [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
34. P149 Median arcuate ligament syndrome (Mals-Dunbar syndrome) in prepubertal patient: case report
- Author
-
Illiceto, M.T., primary, Lisi, G., additional, Filippone, M., additional, Marino, N., additional, Di Pietro, M., additional, Lombardi, G., additional, and Lelli Chiesa, P., additional
- Published
- 2018
- Full Text
- View/download PDF
35. Royal Factionalism and Saudi Foreign Policy
- Author
-
Cooley, John K. and De Marino, N.
- Published
- 1979
- Full Text
- View/download PDF
36. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting
- Author
-
Prati, D, Gasbarrini, A, Mazzotta, F, Sagnelli, E, Carosi, G, Abrescia, N, Alberti, Alfredo, Ambu, S, Andreone, P, Andriulli, A, Angelico, M, Antonucci, G, Ascione, A, Belli, Ls, Bruno, R, Bruno, S, Burra, Patrizia, Camma, C, Caporaso, N, Cariti, G, Cillo, U, Coppola, N, Craxi, A, DE LUCA, A, DE MARTIN, E, DI MARCO, V, Fagiuoli, S, Ferrari, C, Gaeta, Gb, Galli, M, Grieco, A, Grossi, P, Licata, A, Maida, I, Mangia, A, Marino, N, Maserati, R, Missale, G, Mondelli, M, Nasta, P, Niro, G, Persico, M, Petrelli, E, Picciotto, A, Piscaglia, F, Pollicino, T, Puoti, C, Puoti, M, Raimondo, G, Rumi, Mg, Santantonio, T, Smedile, A, Squadrito, G, Baroni, Gs, Taliani, G, Tavio, M, Toti, M, Bonino, F, Brunetto, Mr, Cacopardo, B, Caremani, M, Cauda, R, Colombo, M, DI PERRI, G, Donato, F, Farci, P, Fattovich, G, Filice, G, Ghinelli, F, Guadagnino, V, Lazzarin, A, Levrero, M, Licata, G, Orani, A, Paffetti, A, Pastore, G, Piccinino, F, Pizzigallo, E, Pontisso, Patrizia, Portelli, V, Rizzetto, M, Rossi, A, Stroffolini, T, Ubaldi, E, Santantanio, T, Alberti, A., Antonucci, Gf, Craxi, A., Prati D, Gasbarrini A, Mazzotta F, Sagnelli E, Carosi G, Abrescia N, Alberti A, Ambu S, Andreone P, Andriulli A, Angelico M, Antonucci GF, Ascione A, Belli LS, Bruno R, Bruno S, Burra P, Cammà, C, Caporaso N, Cariti G, Cillo U, Coppola N, Craxì, A, De Luca A, De Martin E, Di Marco, V, Fagiuoli S, Ferrari C, Gaeta GB, Galli M, Grieco A, Grossi P, Licata, A, Maida I, Mangia A, Marino N, Maserati R, Missale G, Mondelli M, Nasta P, Niro G, Persico M, Petrelli E, Picciotto A, Piscaglia F, Pollicino T, Prati D, Puoti C, Puoti M, Raimondo G, Rumi MG, Sagnelli E, Santantonio T, Smedile A, Squadrito G, Baroni GS, Taliani G, Tavio M, Toti M, Bonino F, Brunetto MR, Cacopardo B, Caremani M, Cauda R, Colombo M, Di Perri G, Donato F, Farci P, Fattovich G, Filice G, Ghinelli F, Guadagnino V, Lazzarin A, Levrero M, Licata G, Orani A, Paffetti A, Pastore G, Piccinino F, Pizzigallo E, Pontisso P, Portelli V, Rizzetto M, Rossi A, Stroffolini T, Ubaldi E., Italian Association for the Study of the Liver, Italian Society of Infectious, Tropical Disease, Italian Society for the Study of Sexually Transmitted Diseases: Prati D., Gasbarrini A., Mazzotta F., Sagnelli E., Carosi G., Abrescia N., Alberti A., Ambu S., Andreone P., Andriulli A., Angelico M., Antonucci G.F., Ascione A., Belli L.S., Bruno R., Bruno S., Burra P., Cammà C., Caporaso N., Cariti G., Cillo U., Coppola N., Craxì A., De Luca A., De Martin E., Di Marco V., Fagiuoli S., Ferrari C., Gaeta G.B., Galli M., Grieco A., Grossi P., Licata A., Maida I., Mangia A., Marino N., Maserati R., Missale G., Mondelli M., Nasta P., Niro G., Persico M., Petrelli E., Picciotto A., Piscaglia F., Pollicino T., Puoti C., Puoti M., Raimondo G., Rumi M.G., Santantonio T., Smedile A., Squadrito G., Baroni G.S., Taliani G., Tavio M., Toti M., Bonino F., Brunetto M.R., Cacopardo B., Caremani M., Cauda R., Colombo M., Di Perri G., Donato F., Farci P., Fattovich G., Filice G., Ghinelli F., Guadagnino V., Lazzarin A., Levrero M., Licata G., Orani A., Paffetti A., Pastore G., Piccinino F., Pizzigallo E., Pontisso P., Portelli V., Rizzetto M., Rossi A., Stroffolini T., Ubaldi E., Prati, D, Gasbarrini, A, Mazzotta, F, Sagnelli, E, Carosi, G, Abrescia, N, Alberti, A, Ambu, S, Andreone, P, Andriulli, A, Angelico, M, Antonucci, G, Ascione, A, Belli, L, Bruno, R, Bruno, S, Burra, P, Caporaso, N, Cariti, G, Cillo, U, Coppola, N, De Luca, A, De Martin, E, Fagiuoli, S, Ferrari, C, Gaeta, G, Galli, M, Grieco, A, Grossi, P, Maida, I, Mangia, A, Marino, N, Maserati, R, Missale, G, Mondelli, M, Nasta, P, Niro, G, Persico, M, Petrelli, E, Picciotto, A, Piscaglia, F, Pollicino, T, Puoti, C, Puoti, M, Raimondo, G, Rumi, M, Santantonio, T, Smedile, A, Squadrito, G, Baroni, G, Taliani, G, Tavio, M, Toti, M, Bonino, F, Brunetto, M, Cacopardo, B, Caremani, M, Cauda, R, Colombo, M, Di Perri, G, Donato, F, Farci, P, Fattovich, G, Filice, G, Ghinelli, F, Guadagnino, V, Lazzarin, A, Levrero, M, Licata, G, Orani, A, Paffetti, A, Pastore, G, Piccinino, F, Pizzigallo, E, Pontisso, P, Portelli, V, Rizzetto, M, Rossi, A, Stroffolini, T, and Ubaldi, E
- Subjects
Liver Cirrhosis ,ANTIVIRAL TREATMENT ,Human immunodeficiency virus (HIV) ,HIV Infections ,Hepacivirus ,ANTIVIRAL THERAPY ,PEGYLATED INTERFERON-ALPHA-2B ,LIVER-TRANSPLANTATION ,PEGINTERFERON ALPHA-2A ,HIV-INFECTED PATIENTS ,VIRUS-COINFECTED PATIENTS ,RAPID VIROLOGICAL RESPONSE ,Antiviral therapy ,medicine.disease_cause ,Gastroenterology ,Polyethylene Glycols ,HBV ,guidelines ,Acute hepatitis ,Chronic hepatitis ,Settore MED/12 - Gastroenterologia ,liver transplantation ,Hepatitis C ,Recombinant Proteins ,acute hepatitis ,antiviral therapy ,chronic hepatitis ,cirrhosis ,elderly patients ,hbv ,hcv ,hdv ,hiv ,CLINICAL PRACTICE GUIDELINES ,Cirrhosis ,HCV ,Drug Therapy, Combination ,Antiviral therapy Acute hepatitis Chronic hepatitis,Cirrhosis, Elderly patients, HBV, HCV, HDV, HIV Liver transplantation ,Elderly patient ,Acute hepatiti ,medicine.medical_specialty ,Genotype ,Alpha interferon ,Interferon alpha-2 ,CHRONIC HEPATITIS C ,Antiviral Agents ,Hepatitis B, Chronic ,Internal medicine ,HDV ,Drug Resistance, Viral ,Ribavirin ,medicine ,Humans ,Cirrhosi ,Hepatology ,business.industry ,Settore MED/09 - MEDICINA INTERNA ,Interferon-alpha ,HIV ,Hepatitis C, Chronic ,medicine.disease ,Elderly patients ,Family medicine ,Expert opinion ,Chronic hepatiti ,business - Abstract
It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies.
- Published
- 2010
37. Severe Bone Marrow Suppression Associated with Use of Clopidogrel
- Author
-
Spaccavento C, Zacharia G, Randhawa A, and Marino N
- Subjects
0301 basic medicine ,medicine.medical_specialty ,business.industry ,030204 cardiovascular system & hematology ,Clopidogrel ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Bone marrow suppression ,Adverse drug event ,Open access publishing ,Internal medicine ,Medicine ,business ,medicine.drug - Published
- 2016
38. Pluronic (R) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
- Author
-
Pellosi, D. S., Moret, F., Fraix, A., Marino, N., Maiolino, S., Gaio, E., Hioka, N., Reddi, E., Sortino, Salvatore, and Quaglia, F.
- Published
- 2016
39. Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy
- Author
-
Antonucci G, Mazzotta F, Puoti M, Angeletti C, Girardi E, Santantonio T, Ambu S, Colucci M, Angarano G, Marino N, Rinaldi R, Bellissima P, Armignacco O, Carosi G, Sagnelli E, Coorte Epatiti B. SIMIT Group, GAETA, Giovanni Battista, Antonucci, G, Mazzotta, F, Puoti, M, Angeletti, C, Girardi, E, Santantonio, T, Ambu, S, Gaeta, Giovanni Battista, Colucci, M, Angarano, G, Marino, N, Rinaldi, R, Bellissima, P, Armignacco, O, Carosi, G, Sagnelli, E, and Coorte Epatiti B., SIMIT Group
- Abstract
A multicentre cross-sectional survey was performed to provide an accurate picture of patients with chronic hepatitis B (CHB) cared for by Italian Infectious Diseases Centers (IDCs). This analysis describes factors associated with access to the treatment of CHB in a country where barriers to treatment are not expected to exist because of comprehensive coverage under the National Health System (NHS). The study was performed in 74 IDCs. The analysis focused on 3305 patients with CHB of 3760 HBsAg-positive patients enrolled from March to September, 2008. To account for missing values, a Multiple Imputation method was used. Treatment was reported in 2091 (63.3%) patients. In the multivariate analysis, an increased chance of getting treatment was independently associated with 10 years increase of age at diagnosis (adjusted odds ratio [aOR] 1.2, 95% confidence interval [CI] 1.1-1.3, P < 0.001), HBeAg positivity (aOR 1.8, 95% CI 1.1-2.8, P < 0.001), cirrhosis (aOR 3.6, 95% CI 2-6.3, P = 0.012), HDV (aOR 1.6, 95% CI 1.02-2.5, P = 0.042) and HIV positivity (aOR 6.5, 95% CI 4-10.8, P < 0.001). Conversely, a decreased chance was associated with female gender (aOR 0.6, 95% CI 0.5-0.7, P < 0.001), immigration (aOR 0.6, 95% CI 0.5-0.9, P = 0.009), alcohol consumption (aOR 0.7, 95% CI 0.5-0.98, P = 0.04) and HCV positivity (aOR 0.5, 95% CI 0.3-0.8, P = 0.005). Our study shows that Italian IDCs treat a high percentage of patients with CHB. Nevertheless, disparities exist which are not related to the severity of disease limiting access to antiviral therapy of CHB, even in a country with a universal healthcare system.
- Published
- 2012
40. IL RESTAURO DEL TEATRO COMUNALE 'Salvatore Cicero' Cronaca di un cantiere
- Author
-
ASTA, Francesco, La Grua, D, Marino, N, Saya, P, Portera, D, Di Francesca, E, Varzi, A, Matassa, S, Dispena, S, De Gennaro, R., La Grua, D, Marino, N, Saya, P, Portera, D, Di Francesca, E, Varzi, A, Matassa, S, Dispena, S, De Gennaro, R, and Asta, F
- Subjects
restauro, teatro, cefalu', cantiere ,Settore ICAR/19 - Restauro - Abstract
Trttasi di un testo corredato da diverse immagini che illustra le varie e complesse fasi di un restauro monumentale. Dall'analisi storico-critica del manufatto,attraverso un raffronto con l'origine e l'evoluzione del teatro all'italiana,il saggio tratta della metodologia di intervento in ordine alle tecniche di consolidameto, agli aspetti impiantistici,al ripristino degli apparati decorativi ed al restauro pittorico.Il confronto tra l'opera prima dell'intervento e la sua rstituzione è condotto attraverso la illustrazione delle diverse fasi in cui si è sviluppato il cantiere, seguendo i metodi più moderni del restauro scientifico.
- Published
- 2010
41. Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma
- Author
-
DE MITRI, MARIA STELLA, CASSINI, ROMINA, ANDREONE, PIETRO, BERNARDI, MAURO, Bagaglio S, Morsica G, Marino N, De Mitri MS, Cassini R, Bagaglio S, Morsica G, Andreone P, Marino N, and Bernardi M.
- Subjects
CIRRHOSIS ,HEPATITIS C VIRUS ,HEPATOCELLULAR CARCINOMA ,NON-STRUCTURAL 5 A PROTEIN - Published
- 2007
42. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort
- Author
-
Postorino, M. C, Prosperi, M., QUIROS ROLDAN, Maria Eugenia, Maggiolo, F., Di Giambenedetto, S., Saracino, A., Costarelli, S., Lorenzotti, S., Sighinolfi, L., Di Pietro, M., Torti, Carlo, Castelli, Francesco, Carosi, Giampiero, Nasta, Paola, Paraninfo, G., Foca', Emanuele, Torti, C., Cauda, R., Fabbiani, M., Colafigli, M., Scalzini, Alfredo, Castelnuovo, F., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Ladisa, N., Monno, L., Maggi, Paolo, Pan, A., Gori, A., Lapadula, G., Ospedale, S., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Policlinico, S., Postorino, M. C., Prosperi, M., Quiros-Roldan, E., Maggiolo, F., Di Giambenedetto, S., Saracino, A., Costarelli, S., Lorenzotti, S., Sighinolfi, L., Di Pietro, M., Torti, C., Castelli, F., Carosi, G., Nasta, P., Paraninfo, G., Foca, E., Cauda, R., Fabbiani, M., Colafigli, M., Scalzini, A., Castelnuovo, F., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Ladisa, N., Monno, L., Maggi, P., Pan, A., Gori, A., Lapadula, G., Ospedale, S., Puoti, M., Viale, P., Colangeli, V., Borderi, M., and Policlinico, S.
- Subjects
Cyclopropanes ,Male ,AIDS event ,HIV Infections ,Cohort Studies ,chemistry.chemical_compound ,Antiretroviral Therapy, Highly Active ,HIV Infection ,Viral ,immunological response ,ritonavir-boosted protease inhibitors ,composite outcome ,virus diseases ,Lopinavir ,General Medicine ,Hepatitis C ,Middle Aged ,Viral Load ,non-nucleoside reverse transcriptase inhibitors ,Death ,Ritonavir-boosted protease inhibitor ,Treatment Outcome ,Infectious Diseases ,Anti-Retroviral Agents ,Italy ,Alkynes ,Cohort ,RNA, Viral ,Female ,Viral load ,Human ,medicine.drug ,Cohort study ,Benzoxazine ,Adult ,Microbiology (medical) ,medicine.medical_specialty ,Efavirenz ,Atazanavir Sulfate ,virological response ,Antiretroviral Therapy ,Non-nucleoside reverse transcriptase inhibitor ,AIDS events ,Composite outcome ,Deaths ,First-line therapy ,Immunological response ,Non-nucleoside reverse transcriptase inhibitors ,Ritonavir-boosted protease inhibitors ,Virological response ,Benzoxazines ,CD4 Lymphocyte Count ,Humans ,Ritonavir ,Settore MED/17 - MALATTIE INFETTIVE ,first-line therapy ,Internal medicine ,medicine ,Highly Active ,business.industry ,Odds ratio ,medicine.disease ,deaths ,chemistry ,Immunology ,RNA ,Anti-Retroviral Agent ,Cohort Studie ,business - Abstract
Randomized trials and observational cohorts reported higher rates of virological suppression after highly active antiretroviral therapy (HAART) including efavirenz (EFV), compared with boosted protease inhibitors (PIs). Correlations with immunological and clinical outcomes are unclear. Patients of the Italian MASTER cohort who started HAART from 2000 to 2010 were selected. Outstanding outcome (composite outcome for success (COS)) was introduced. We evaluated predictors of COS (no AIDS plus CD4+ count >500/mm3 plus HIV-RNA
- Published
- 2015
43. Endoscopic-assisted Heller extramucosal myotomy with antireflux anterior fundoplication (DOR) in robotic approach for esophageal achalasia (EA)
- Author
-
Illiceto, M.T., primary, Lisi, G., additional, Filippone, M., additional, Marino, N., additional, Chiesa, P. Lelli, additional, and Lombardi, G., additional
- Published
- 2016
- Full Text
- View/download PDF
44. Unexpected Left Atrial Reinfusion through a Patent Foramen Ovale during Venovenous Extracorporeal Life Support
- Author
-
Marino, N. Bottino A., primary, Polli, F., additional, Savioli, M., additional, Tubiolo, D., additional, Iapichino, G. E., additional, Protti, A., additional, and Gattinoni, L., additional
- Published
- 2016
- Full Text
- View/download PDF
45. Overexpression of h-prune in breast cancer is correlated with advanced disease status
- Author
-
Zollo, M., Andrè, A., Antonio Giuseppe Maria COSSU, Sini, M. C., D Angelo, A., Marino, N., Budroni, M., Tanda, F., Arrigoni, G., Palmieri, G., Zollo, Massimo, Andr, A, Cossu, A, SINI M., C, D'Angelo, A, Marino, N, Budroni, M, Tanda, F, Arrigoni, G, and Palmieri, G.
- Subjects
Cancer Research ,Time Factors ,progressione tumorale ,Breast Neoplasms ,Disease-Free Survival ,Cohort Studies ,fattore di prognosi ,Humans ,Neoplasm Metastasis ,In Situ Hybridization, Fluorescence ,Oligonucleotide Array Sequence Analysis ,Proportional Hazards Models ,fungi ,Carcinoma ,DNA ,carcinoma mammario ,Immunohistochemistry ,formazione metastasi ,Phosphoric Monoester Hydrolases ,nervous system ,Oncology ,Chromosomes, Human, Pair 1 ,Lymphatic Metastasis ,Regression Analysis ,Female ,Carrier Proteins ,Follow-Up Studies - Abstract
Purpose: The h-prune gene is involved in cellular motility and metastasis formation in breast cancer through interacting with the nm23-H1 protein. The aim of this study was to better define the clinical and pathologic role of h-prune in breast cancer patients. Experimental Design: Using immunohistochemistry, we assessed h-prune and nm23-H1 protein expression in two series of breast cancer patients: (i) in 2,109 cases with pathologic reports on primary tumors and (ii) in 412 cases with detailed clinical information. To assess the role of DNA amplification in gene activation, the h-prune copy number was evaluated by fluorescence in situ hybridization analysis in 1,016 breast cancer cases. Results: In the patients tested (n = 2,463), 1,340 (54%) had an increased level of h-prune expression; a positive immunostaining for nm23-H1 was observed in 615 of 2,061 (30%) cases. Overexpression of h-prune was associated with multiple gene copy number at chromosome 1q21.3 in a very limited fraction of cases (68 of 1,016; 6.7%), strongly indicating that alternative pathways induce h-prune activation in breast cancer. Multivariate Cox regression analysis showed that neither h-prune overexpression nor decreased nm23-H1 immunostaining is independent prognostic factors. However, a significant association of h-prune overexpression with either advanced lymph node status (P = 0.017) or presence of distant metastases (P = 0.029) was observed. Conclusions: Although not significantly correlated with overall survival, positive h-prune immunostaining identifies subsets of breast cancer patients with higher tumor aggressiveness. Further investigations using larger collections of advanced breast cancer patients are required for assessing the predictive role of h-prune in breast cancer.
- Published
- 2005
46. Pain Intensity and Threshold in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Correlations with the Hamilton Depression Rating Scale
- Author
-
Bagnato, Gianfilippo, Atteritano, Marco, Sorbara, S., De Andres, I., Talotta, R., Corallo, G., Verduci, E., Miceli, G., Sangari, D., Visalli, E., Marino, N., Morgante, S., Roberts, W. N., and Bagnato, Gianluca
- Published
- 2013
47. An Innovative PET Detector Concept for TOF-Inbeam PET Dosimetry in Hadron-Therapy
- Author
-
Bisogni, M. G., Ambrosi, G., Cerello, P., Marzocca, Cristoforo, Corsi, Francesco, Del Guerra, A., Licciulli, Francesco, De Luca, G., Marino, N., Pennazio, F., Borgese, G., Fanucci, L., Baronti, F., Roncella, R., and Wheadon, R.
- Published
- 2012
48. Dendrimeri triscalix[4]arenici a simmetria c3 solubili in acqua
- Author
-
Gattuso, Giuseppe, Grasso, G., Marino, N., Notti, Anna, Pappalardo, A., Pappalardo, S., and Parisi, Melchiorre
- Published
- 2011
49. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
- Author
-
Torti, Carlo, d'Arminio Monforte, A, Pozniak, Al, Lapadula, G, Cologni, G, Antinori, A, De Luca, A, Mussini, C, Castagna, A, Cicconi, P, Minoli, L, Costantini, A, Carosi, Giampiero, Liang, H, Cesana, Bm, Master, Chelsea, Westminster, Icona, Modena, Collaborators: Carosi G, S. Raffaele HIV C. o. h. o. r. t. s., Puoti, M, Torti, C, QUIROS ROLDAN, Maria Eugenia, Paraninfo, G, Casari, S, Pastore, G, Ladisa, N, Suter, F, Maggiolo, F, Quirino, T, Migliorino, M, Ghinelli, F, Sighinolfi, L, Mazzotta, F, Lo Caputo, S, Marino, N, Angarano, A, Saracino, A, D'Arminio Monforte, A, Maserati, R, Novati, S, Tinelli, C, Antonucci, G, Ammassari, A, Cauda, R, Montroni, M, Scalise, G, Braschi, Mc, Riva, A, Tirelli, U, Martellotta, F, Minafra, G, Arici, C, Chiodo, F, Colangeli, V, Fiorini, C, Coronado, O, Carosi, G, Cristini, G, Minardi, C, Bertelli, D, Melzi, S, Manconi, Pe, Piano, P, Cosco, L, Scerbo, A, Pizzigallo, E, D'Alessandro, M, Santoro, D, Pusterla, L, Carnevale, G, Zoncada, A, Viganò, P, Mena, M, Leoncini, F, Pozzi, M, Angarano, G, Grisorio, B, Ferrara, S, Grima, P, Tundo, P, Pagano, G, Cassola, G, Alessandrini, A, Piscopo, R, Toti, M, Trezzi, M, Soscia, F, Tacconi, L, Orani, A, Perini, P, Scasso, A, Vincenti, A, Chiodera, F, Castelli, P, Scalzini, A, Palvarini, L, Moroni, M, Lazzarin, A, Rizzardini, G, Caggese, L, Repetto, D, Galli, A, Merli, S, Pastecchia, C, Moioli, Mc, Esposito, R, Abrescia, N, Chirianni, A, Izzo, Cm, Piazza, M, De Marco, M, Viglietti, R, Manzillo, E, Nappa, S, Colomba, A, Abbadessa, V, Prestileo, T, Mancuso, S, Ferrari, C, Pizzaferri, P, Filice, G, Bruno, R, Baldelli, F, Camanni, G, Petrelli, E, Cioppi, A, Alberici, F, Ruggieri, A, Menichetti, F, Martinelli, C, De Stefano, C, La Gala, A, Ballardini, G, Rizzo, E, Magnani, G, Ursitti, Ma, Arlotti, M, Ortolani, P, Dianzani, F, Ippolito, G, Ciardi, M, Narciso, P, Petrosillo, N, Vullo, V, Zaccarelli, M, Acinapura, R, De Longis, P, Murri, R, Trotta, Mp, Noto, P, Lichtner, M, Capobianchi, Mr, Carletti, F, Perno, Cf, Girardi, E, Pezzotti, P, Rezza, G, Mura, Ms, Mannazzu, M, Caramello, P, Di Perri, G, Orofino, Gc, Sciandra, M, Grossi, Pa, Basilico, C, Poggio, A, Bottari, G, Raise, E, Ebo, F, Pellizzer, G, Buonfrate, D, Resta, F, Loso, K, Cozzi Lepri, A, Borghi, V, Galli, L, Sampietro, S, Mandalia, S, and Gazzard, B.
- Published
- 2011
50. Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection
- Author
-
Svicher, V, Cento, V, Bernassola, M, Neumann Fraune, M, Salpini, R, Longo, R, Visca, M, Romano, S, Michieli, V, Bertoli, A, Gubertini, G, Marino, N, Mazzotta, F, Sarrecchia, C, Andreoni, M, Angelico, M, Ursitti, A, Spanò, A, CECCHERINI SILBERSTEIN, F, Verheyen, J, Cappiello, G, and Perno, Cf
- Subjects
Settore MED/07 - Microbiologia e Microbiologia Clinica - Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.